Stay updated on Global Cohort Study: Remibrutinib Clinical Trial
Sign up to get notified when there's something new on the Global Cohort Study: Remibrutinib Clinical Trial page.

Latest updates to the Global Cohort Study: Remibrutinib Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedFooter updates include Revision: v3.3.3 added and removal of HHS Vulnerability Disclosure and Revision: v3.3.2; these changes do not affect study content or navigation on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page now uses an 'Last Update Posted (Estimated)' label and includes December 2025 update dates, while the prior 'Last Update Posted' label and 2024 timestamp entries have been removed.SummaryDifference0.4%

- Check37 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 as minor maintenance notes displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoval of the government funding lapse notice banner; the rest of the page content, including the study details and contacts, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedMAP Cohort page now shows revised inclusion/exclusion criteria and updated enrollment contact information and locations for Remibrutinib in adults with CSU. These details guide potential participants on eligibility and how to initiate access.SummaryDifference0.2%

- Check87 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference4%

Stay in the know with updates to Global Cohort Study: Remibrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Global Cohort Study: Remibrutinib Clinical Trial page.